Please assess the completion status of the following clinical trial:

Trial Title: A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar With Type 2 Diabetes Mellitus

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~* Subjects with Type 2 Diabetes Mellitus,~* Subjects on antidiabetic treatment (oral and/or insulin therapy) for \> 6 months,~* Subjects who require a basal long-acting insulin for the control of hyperglycaemia,~* HbA1c values \> 7.0% and \< 12 %,~* BMI \< 40 kg/m².~The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).